FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891340170> ?p ?o ?g. }

• W2891340170 endingPage "10720" @default.
• W2891340170 startingPage "10712" @default.
• W2891340170 abstract "This study investigated whether the anthocyanin cyanidin-3-O-β-glucoside (Cy-3-g) could affect platelet apoptosis and proplatelet formation in vitro. Thrombin-stimulated or resting human platelets and Meg-01 megakaryocytes were incubated with Cy-3-g (0, 0.5, 5, or 50 μM). We found that the percentage of the platelet mitochondrial membrane potential treated with 5 and 50 μM Cy-3-g was significantly higher than control (15.50% ± 3.24% and 29.77% ± 4.06% versus 2.76% ± 1.33%, respectively; P < 0.05). Treatment with 5 and 50 μM Cy-3-g significantly increased phosphatidylserine exposure compared with control (40.56% ± 10.53% and 76.62% ± 8.28% versus 15.43% ± 3.93%, respectively; P < 0.05). Moreover, Cy-3-g significantly increased the expression of Bax, Bak, and cytochrome c while markedly decreasing Bcl-xL and Bcl-2 expression as well as stimulating caspase-3, caspase-9, caspase-8, Bid, and gelsolin cleavage in thrombin-activated platelets in a dose-dependent manner (P < 0.05). However, no significant differences were observed in the apoptosis of resting platelets when treated with Cy-3-g (P > 0.05). Furthermore, Cy-3-g significantly (P < 0.05) enhanced cell viability (50 μM versus control, 1.34 ± 0.01 versus 0.35 ± 0.02), the number of colony-forming unit-megakaryocytes (50 μM versus control, 38 ± 3 versus 8 ± 3), CD41 expression (50 μM versus control, 96.80% ± 2.55% versus 25.57% ± 2.86%), DNA ploidy (16N) (50 μM versus control, 19.73% ± 2.34% versus 4.42% ± 1.96%), and proplatelet formation (50 μM versus control, 27.5% ± 3.77% versus 7.67% ± 2.25%) in Meg-01 cells. In conclusion, Cy-3-g promotes activated platelet apoptosis and enhances megakaryocyte proliferation, differentiation, and proplatelet formation in vitro." @default.
• W2891340170 created "2018-09-27" @default.
• W2891340170 creator A5000890886 @default.
• W2891340170 creator A5008583143 @default.
• W2891340170 creator A5020575927 @default.
• W2891340170 creator A5021352155 @default.
• W2891340170 creator A5022482080 @default.
• W2891340170 creator A5036185277 @default.
• W2891340170 creator A5036994812 @default.
• W2891340170 creator A5037325124 @default.
• W2891340170 creator A5084685500 @default.
• W2891340170 date "2018-09-18" @default.
• W2891340170 modified "2023-10-10" @default.
• W2891340170 title "Cyanidin-3-O-β-glucoside, a Natural Polyphenol, Exerts Proapoptotic Effects on Activated Platelets and Enhances Megakaryocytic Proplatelet Formation" @default.
• W2891340170 cites W1829315865 @default.
• W2891340170 cites W1964864548 @default.
• W2891340170 cites W1976197588 @default.
• W2891340170 cites W1977258127 @default.
• W2891340170 cites W1980917241 @default.
• W2891340170 cites W1983672911 @default.
• W2891340170 cites W1989737463 @default.
• W2891340170 cites W1990696872 @default.
• W2891340170 cites W1991391101 @default.
• W2891340170 cites W1993299969 @default.
• W2891340170 cites W1995311382 @default.
• W2891340170 cites W2000863779 @default.
• W2891340170 cites W2010231461 @default.
• W2891340170 cites W2010267898 @default.
• W2891340170 cites W2012173045 @default.
• W2891340170 cites W2015948321 @default.
• W2891340170 cites W2021171647 @default.
• W2891340170 cites W2027136024 @default.
• W2891340170 cites W2035430096 @default.
• W2891340170 cites W2035701793 @default.
• W2891340170 cites W2039640090 @default.
• W2891340170 cites W2048284951 @default.
• W2891340170 cites W2054821098 @default.
• W2891340170 cites W2055339187 @default.
• W2891340170 cites W2075376229 @default.
• W2891340170 cites W2079429160 @default.
• W2891340170 cites W2091851381 @default.
• W2891340170 cites W2099808035 @default.
• W2891340170 cites W2132599832 @default.
• W2891340170 cites W2136478232 @default.
• W2891340170 cites W2138980714 @default.
• W2891340170 cites W2142700037 @default.
• W2891340170 cites W2144158374 @default.
• W2891340170 cites W2146974608 @default.
• W2891340170 cites W2156484966 @default.
• W2891340170 cites W2161241686 @default.
• W2891340170 cites W2167203608 @default.
• W2891340170 cites W2206901079 @default.
• W2891340170 cites W2308354034 @default.
• W2891340170 cites W2346435304 @default.
• W2891340170 cites W2396264007 @default.
• W2891340170 cites W2412688330 @default.
• W2891340170 cites W2480001487 @default.
• W2891340170 cites W2529303914 @default.
• W2891340170 cites W2529718400 @default.
• W2891340170 cites W2529871586 @default.
• W2891340170 cites W2600669583 @default.
• W2891340170 cites W2752383102 @default.
• W2891340170 cites W2764229056 @default.
• W2891340170 cites W2806705401 @default.
• W2891340170 doi "https://doi.org/10.1021/acs.jafc.8b03266" @default.
• W2891340170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30226049" @default.
• W2891340170 hasPublicationYear "2018" @default.
• W2891340170 type Work @default.
• W2891340170 sameAs 2891340170 @default.
• W2891340170 citedByCount "11" @default.
• W2891340170 countsByYear W28913401702019 @default.
• W2891340170 countsByYear W28913401702020 @default.
• W2891340170 countsByYear W28913401702021 @default.
• W2891340170 countsByYear W28913401702022 @default.
• W2891340170 countsByYear W28913401702023 @default.
• W2891340170 crossrefType "journal-article" @default.
• W2891340170 hasAuthorship W2891340170A5000890886 @default.
• W2891340170 hasAuthorship W2891340170A5008583143 @default.
• W2891340170 hasAuthorship W2891340170A5020575927 @default.
• W2891340170 hasAuthorship W2891340170A5021352155 @default.
• W2891340170 hasAuthorship W2891340170A5022482080 @default.
• W2891340170 hasAuthorship W2891340170A5036185277 @default.
• W2891340170 hasAuthorship W2891340170A5036994812 @default.
• W2891340170 hasAuthorship W2891340170A5037325124 @default.
• W2891340170 hasAuthorship W2891340170A5084685500 @default.
• W2891340170 hasConcept C153911025 @default.
• W2891340170 hasConcept C16685009 @default.
• W2891340170 hasConcept C185592680 @default.
• W2891340170 hasConcept C190283241 @default.
• W2891340170 hasConcept C203014093 @default.
• W2891340170 hasConcept C2778918659 @default.
• W2891340170 hasConcept C2779637612 @default.
• W2891340170 hasConcept C29311851 @default.
• W2891340170 hasConcept C41625074 @default.
• W2891340170 hasConcept C55493867 @default.
• W2891340170 hasConcept C71924100 @default.
• W2891340170 hasConcept C86803240 @default.
• W2891340170 hasConcept C89560881 @default.

• next